Search research articles
Contact Us
Filters
Showing results (131-140 of 801) with videos related to
Page
of 81
Sort By:
The New England Journal of Medicine
|
December 8, 2025
Enhancing FDA Drug-Safety Surveillance - Beyond Releasing Daily Adverse-Event Data
Joshua D Wallach, Joseph S Ross, Reshma Ramachandran
JAMA Internal Medicine
|
June 12, 2023
Approval of Drugs With Unmet Trial End Points-In Reply
James L Johnston, Joseph S Ross, Reshma Ramachandran
BMJ Open
|
November 14, 2015
Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012
Jennifer E Miller, David Korn, Joseph S Ross
Clinical Trials (London, England)
|
June 7, 2018
The US Food and Drug Administration's expedited approval programs: Addressing premarket flexibility with enhanced postmarket evidence generation
Joshua D Wallach, Joseph S Ross, Huseyin Naci
The New England Journal of Medicine
|
November 15, 2023
Data Sharing - A New Era for Research Funded by the U.S. Government
Joseph S Ross, Joanne Waldstreicher, Harlan M Krumholz
JAMA Network Open
|
April 1, 2026
Advertising Payments to News Websites That Publish Health Misinformation
Neeraj G Patel, Reshma Ramachandran, Joseph S Ross
JAMA Network Open
|
June 26, 2023
US Food and Drug Administration Review Time of Supplemental New Indication Approvals of Drugs and Biologics, 2017 to 2019
Meera M Dhodapkar, Joseph S Ross, Reshma Ramachandran
Plos One
|
July 20, 2018
Patterns and predictors of off-label prescription of psychiatric drugs
Aishwarya Vijay, Jessica E Becker, Joseph S Ross
JAMA
|
July 21, 2018
Clinical Trial Evidence Supporting FDA Approval of Drugs Granted Breakthrough Therapy Designation
Jeremy Puthumana, Joshua D Wallach, Joseph S Ross
JAMA Network Open
|
May 14, 2025
Ransomware Attacks and Data Breaches in US Health Care Systems
John Xuefeng Jiang, Joseph S Ross, Ge Bai
Page
of 81
Search research articles
Search
Showing results (131-140 of 801) with videos related to
Sort By:
Page
of 81
The New England Journal of Medicine
|
December 8, 2025
Enhancing FDA Drug-Safety Surveillance - Beyond Releasing Daily Adverse-Event Data
Joshua D Wallach, Joseph S Ross, Reshma Ramachandran
JAMA Internal Medicine
|
June 12, 2023
Approval of Drugs With Unmet Trial End Points-In Reply
James L Johnston, Joseph S Ross, Reshma Ramachandran
BMJ Open
|
November 14, 2015
Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012
Jennifer E Miller, David Korn, Joseph S Ross
Clinical Trials (London, England)
|
June 7, 2018
The US Food and Drug Administration's expedited approval programs: Addressing premarket flexibility with enhanced postmarket evidence generation
Joshua D Wallach, Joseph S Ross, Huseyin Naci
The New England Journal of Medicine
|
November 15, 2023
Data Sharing - A New Era for Research Funded by the U.S. Government
Joseph S Ross, Joanne Waldstreicher, Harlan M Krumholz
JAMA Network Open
|
April 1, 2026
Advertising Payments to News Websites That Publish Health Misinformation
Neeraj G Patel, Reshma Ramachandran, Joseph S Ross
JAMA Network Open
|
June 26, 2023
US Food and Drug Administration Review Time of Supplemental New Indication Approvals of Drugs and Biologics, 2017 to 2019
Meera M Dhodapkar, Joseph S Ross, Reshma Ramachandran
Plos One
|
July 20, 2018
Patterns and predictors of off-label prescription of psychiatric drugs
Aishwarya Vijay, Jessica E Becker, Joseph S Ross
JAMA
|
July 21, 2018
Clinical Trial Evidence Supporting FDA Approval of Drugs Granted Breakthrough Therapy Designation
Jeremy Puthumana, Joshua D Wallach, Joseph S Ross
JAMA Network Open
|
May 14, 2025
Ransomware Attacks and Data Breaches in US Health Care Systems
John Xuefeng Jiang, Joseph S Ross, Ge Bai
Page
of 81